Clinical Scorecard: Risk Assessment for In-Hospital Mortality in ICU Patients with Cardiovascular Conditions and Diabetes Using Machine Learning Techniques
At a Glance
Category
Detail
Condition
Cardiovascular Disease and Diabetes Mellitus
Key Mechanisms
Insulin resistance, oxidative stress, macrovascular and microvascular damage
Target Population
ICU patients with cardiovascular disease and comorbid diabetes mellitus
Care Setting
Intensive Care Unit
Key Highlights
CVD and DM coexist frequently, increasing mortality risk.
Diabetes-related markers are independently associated with in-hospital mortality.
Machine learning models can predict mortality risk in ICU patients.
SHAP method elucidates variable contributions in predictive models.
Need for specific mortality risk scores for ICU patients with CVD and DM.
Guideline-Based Recommendations
Diagnosis
Utilize machine learning algorithms for risk stratification.
Assess diabetes-related markers in ICU patients.
Management
Implement individualized risk assessment tools in clinical practice.
Monitor blood glucose levels and insulin resistance.
Monitoring & Follow-up
Regularly evaluate clinical data points for risk assessment.
Use SHAP for understanding variable impacts on mortality risk.
Risks
Increased risk of heart failure and myocardial infarction in diabetic patients.
Higher cardiovascular mortality rates in patients with diabetes.
Patient & Prescribing Data
ICU patients aged ≥18 years with cardiovascular disease and diabetes.
Focus on managing diabetes and cardiovascular health to reduce mortality risk.
Clinical Best Practices
Incorporate machine learning models into clinical decision-making.
Ensure consistent data collection for accurate risk assessment.
Utilize external validation datasets for model reliability.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
